We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNY
326
Bank of New York Mellon
BNY
$108B
| $359K | 0.06% |
+6,178
| New | +$355K |
|
327
Freshworks
FRSH
$3.18B
| $359K | 0.06% |
+13,658
| New | +$496K |
|
328
SolarEdge
SEDG
$2.06B
| $359K | 0.06% |
1,279
-21,720
| -94% | -$6.86M |
|
329
Nice
NICE
$5.82B
| $358K | 0.06% |
1,180
-820
| -41% | -$237K |
|
330
Hyatt Hotels
H
$16.9B
| $355K | 0.06% |
+3,701
| New | +$316K |
|
331
Bank of America
BAC
$442B
| $347K | 0.06% |
+7,802
| New | +$355K |
|
332
Popular Inc
BPOP
$11.3B
| $347K | 0.06% |
4,229
-3,571
| -46% | -$290K |
|
333
PBF Energy
PBF
$7.25B
| $347K | 0.06% |
26,752
+12,961
| +94% | +$180K |
|
334
Wyndham Hotels & Resorts
WH
$5.65B
| $347K | 0.06% |
+3,874
| New | +$324K |
|
335
Southern Copper
SCCO
$164B
| $346K | 0.06% |
6,056
-7,685
| -56% | -$429K |
|
336
UGI
UGI
$7.62B
| $344K | 0.06% |
7,486
-16,982
| -69% | -$755K |
|
337
Tenaris
TS
$28.8B
| $342K | 0.06% |
16,372
-100,801
| -86% | -$2.2M |
|
338
Cencora
COR
$61.7B
| $339K | 0.06% |
2,554
-8,556
| -77% | -$1.05M |
|
339
Manhattan Associates
MANH
$11.2B
| $339K | 0.06% |
2,181
+166
| +8% | +$27K |
|
340
American International
AIG
$42.1B
| $338K | 0.06% |
5,939
-7,549
| -56% | -$430K |
|
341
Fortune Brands Innovations
FBIN
$6.24B
| $337K | 0.06% |
3,691
-3,258
| -47% | -$282K |
|
342
TechnipFMC
FTI
$27.2B
| $337K | 0.06% |
56,888
+17,470
| +44% | +$120K |
|
343
ICICI Bank
IBN
$109B
| $336K | 0.06% |
16,955
-56,012
| -77% | -$1.11M |
|
344
Brinker International
EAT
$9.69B
| $334K | 0.06% |
9,127
-2,345
| -20% | -$96.9K |
|
|
AZUL
345
DELISTED
Azul
AZUL
| $332K | 0.06% |
+25,181
| New | +$382K |
|
346
Sysco
SYY
$40.3B
| $331K | 0.06% |
4,212
-8,843
| -68% | -$681K |
|
347
Henry Schein
HSIC
$9.98B
| $330K | 0.06% |
+4,256
| New | +$325K |
|
348
Hayward Holdings
HAYW
$3.43B
| $328K | 0.06% |
+12,509
| New | +$303K |
|
349
Flowers Foods
FLO
$1.57B
| $326K | 0.06% |
+11,870
| New | +$307K |
|
|
FOLD
350
DELISTED
Amicus Therapeutics
FOLD
| $323K | 0.06% |
27,934
+12,234
| +78% | +$136K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.